SOYDAL, Ç. Et Al. 2016. Marked Response to Lu-177 Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer. CLINICAL NUCLEAR MEDICINE , vol.41, no.2 , 159-160.

SOYDAL, Ç., ÖZKAN, E., AKYÜREK, S., & KÜÇÜK, N. Ö., (2016). Marked Response to Lu-177 Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer. CLINICAL NUCLEAR MEDICINE , vol.41, no.2, 159-160.

SOYDAL, ÇİĞDEM Et Al. "Marked Response to Lu-177 Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer," CLINICAL NUCLEAR MEDICINE , vol.41, no.2, 159-160, 2016

SOYDAL, ÇİĞDEM Et Al. "Marked Response to Lu-177 Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer." CLINICAL NUCLEAR MEDICINE , vol.41, no.2, pp.159-160, 2016

SOYDAL, Ç. Et Al. (2016) . "Marked Response to Lu-177 Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer." CLINICAL NUCLEAR MEDICINE , vol.41, no.2, pp.159-160.

@article{article, author={ÇİĞDEM SOYDAL Et Al. }, title={Marked Response to Lu-177 Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer}, journal={CLINICAL NUCLEAR MEDICINE}, year=2016, pages={159-160} }